BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

FOREX INVESTORS BUZZ STOCKS TRADERS BUZZ NEXT WEEK

FOREX INVESTORS BUZZ STOCKS TRADERS WATCH NEXT WEEK

STOCK TRADERS BUZZ STOCKS TRADERS WATCH Key events are scheduled for the companies listed below next week.

STOCK TRADERS BUZZ STOCKS TRADERS WATCH Key events are scheduled for the companies listed below next week.

Notable earnings reports: A tech-heavy list includes 58.com (NYSE:(WUBA) on Aug. 21; Toll Brothers (NYSE:(TOL) on Aug. 22; DSW (NYSE:(DSW) on Aug. 22; JA Solar (NASDAQ(:JASO) on Aug. 22; Cree (NASDAQ:(CREE) on Aug. 22; Salesforce.com (NYSE:(CRM) on Aug. 22; Medtronic (NYSE:(MDT) on Aug. 22; HP (NYSE(:HPQ) on Aug. 23; Eaton Vance (NYSE:EV) on Aug. 23; American Eagle Outfitters (NYSE:(AEO) on Aug. 23; Williams-Sonoma (NYSE:WSM) on Aug. 23; Lannett (NYSEMKT:(LCI) on Aug. 23; Veeva Systems (NYSE:(VEEV) on Aug. 24; Broadcom (NASDAQ:(AVGO) on Aug. 24; Marvell Technology (NASDAQ:(MRVL) on Aug. 24; VMware (NYSE:(VMW) on Aug. 24; GameStop (NYSE:(GME) on Aug. 24; Staples (NASDAQ:(SPLS) on Aug. 24.

IPO quiet period expirations: Co-Diagnostics (Pending:(CODX) on Aug. 21; Redfin (Pending:(RDFN) analyst quiet period expires Aug. 22; Akcea Therapeutics (NASDAQ:(AKCA) on Aug. 23.



STOCKS TRADERS WATCH

Secondary offering lockup expirations: Clovis Oncology (NASDAQ:(CLVS) on Aug. 21; GlycoMimetics (NASDAQ:(GLYC) on Aug. 22; Camping World (NYSE:(CWH) on Aug. 23; Costamare (NYSE:(CMRE) on Aug. 23.

Notable annual meetings: Quality Systems (NASDAQ:(QSII) on Aug. 22; Microchip Technology (NASDAQ:(MCHP) on Aug. 22; Bob Evans Farms (NASDAQ:(BOBE) on Aug. 23; Gladstone Investment (NASDAQ:(GAIN) on Aug. 24; Organovo (NYSEMKT:(ONVO) on Aug. 24.

Special shareholder meetings: Whole Foods (NASDAQ:WFM) holds a shareholder vote on its acquisition by Amazon.com (NASDAQ:(AMZN) Aug. 23 at 9:30 a.m. ET.

Business update call: Fidelity & Guaranty Life (NYSE:FGL) holds its Q3 bondholder call on Aug. 21.

Notable conferences: Heikkinen Energy Conference in Houston Aug. 23 features Southwestern Energy (NYSE:(SWN) and EnLink Midstream (NYSE:(ENLC). CFA Intellisight Conference in Minneapolis Aug. 22-23 features Marcus (NYSE:(MCS) and CorEnergy Infrastructure Trust (NYSE:(CORR).

FDA watch: Alnylam (NASDAQ:(ALNY) holds an update call on RNAi Therapeutics on Aug. 23. Adamas Pharmaceuticals (NASDAQ:(ADMS) has its Pdufa date for ADS-5102 to treat levodopa-induced dyskinesia in patients with Parkinson’s disease on Aug. 24.

OPEC watch: The OPEC/non-OPEC Joint Technical Committee meets in Vienna to assess compliance with production cuts on Aug. 21.

Barron’s mentions: The cover explores why Starbucks (NASDAQ:(SBUX) could jump 20%, with some help from digital payments. Lockheed Martin (NYSE:(LMT) should benefit from an expected boost in military outlays. Gardner Denver (NYSE:(GDI) could see 40% upside after a retooling under (KKR. Motorola Solutions (NYSE:(MSI) faces challenges as a big new public-safety network might supplant the company’s two-way radios. And dividend investors should look beyond pharmaceutical stocks to the healthy yields in the rest of healthcare.




Like up on FACEBOOK


logo

Major Telcom Stocks ( T stock )   ( VZ ) ( TMUS ) ( TWX )  ( CMCSA) ( SSNLF ) ( AAPL )



Marijuana Stock News The marijuana stock market is a constantly updating, evolving beast.

Marijuana Stock News: What Today Means for Marijuana Stocks 2018

Marijuana Stock News

Marijuana Stock News    The marijuana stock market is a constantly updating, evolving beast.

The marijuana stock market is a constantly updating, evolving beast. There’s so much going on day to day in terms of marijuana stock news that it feels like you can’t even keep up sometimes. Because unlike other industries, marijuana stock news is only half about pot stocks, with the other half firmly focused on the political side of one of the most controversial drug movements around: U.S. weed legalization.

So when it comes to pot stocks, they can be some of the more taxing investment opportunities around, even if their potential payoff may warrant that extra legwork on the investor’s part. It’s one of the reasons I like writing about weed stocks so much—I get to combine my passion for politics with my interest in finance and help everyday investors make the right moves in the market by seeing what’s ahead over the horizon.



Marijuana Stock News

U.S. Weed Legalization

No single event in my mind would have a more profound effect on the marijuana stock market than a total U.S. weed legalization policy put in place by the government. While we’re still long ways away from that, even if the majority of Americans have come out in support of legal marijuana, there are some promising signs that point towards a green future.

The most important development would be the bill proposed by Sen. Cory Booker (D-NJ), who not only wants to legalize the drug, but also actively encourage and incentivize the remaining states to follow suit, not to mention dissuade drag on the law by penalizing states that don’t adopt legalization legislation.

This kind of changeover and confluence of ideals has created a difficult balancing act for both legislators and pot activists. Ultimately, for marijuana legalization U.S. to truly blossom, the country needs to have federal protections in place for the drug. Otherwise, no matter how many states pass legislation allowing medicinal and recreational use, there’s no guarantee that the federal government won’t send its agents in to shut the whole operation down. While that scenario is unlikely, the mere threat of it is still daunting for investors.

Not to mention that transportation and shipment of the drug are made needlessly complicated by the current laws in place.

.S. Pot Laws 2017

In direct opposition stands the Trump administration, which has taken a rather regressive view on the legalization of pot in the U.S.

While President Trump went back and forth during the campaign about what he would do concerning marijuana laws in the U.S. (which, to be fair, he did on a number of different issues), he initially said he would follow the Obama model and leave it up to the states. Of course, he never cited Obama by name, but that was the gist of his position in several interviews.

Fast forward to now, and we have a very different Trump on our hands. Part of that, of course, is fueled by the appointment of Attorney General Jeff Sessions.

Sessions is one of the most adamant drug crusaders of our day, and has targeted marijuana as a drug that ought to be curtailed in its use and its proliferation as a legalized substance.

New Marijuana Stock Opportunities 

Medical marijuana and recreational marijuana are both well-covered in terms of how they project to be big, billion-dollar businesses in the near future. But what about other industries that are developing around marijuana?

Just take at the marijuana real estate stock chart below, for example.

marijuana real estate stock chart

 

For instance, if a marijuana grower is operating in Colorado and is growing its product, making a living, abiding by the law, there’s still nothing stopping federal agents from coming in and shutting everything down. Then the company would effectively be killed off and sitting on a ton of land that it can’t do anything with at the moment. That would drive it potentially towards bankruptcy or at the very least create an environment where opportunistic buyers would come in with low-ball offers on the land, looking to take advantage of the misfortunes of the grower.

The marijuana real estate business helps cut these risks for marijuana producers by leasing the land to the companies. The result is that the growers are not on the hook for millions in terms of land investment should they ever be shutdown, while the marijuana real estate company collects rent so long as the marijuana company is in business.




 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



 Tech Stocks These young geniuses pocket enormous sums of money by solving seemingly intractable problems.

Why Tech Stocks Are “Win-Win” Situations

“Technology made large populations possible; large populations now make technology indispensable.”

 Tech Stocks These young geniuses pocket enormous sums of money by solving seemingly intractable problems.

 Tech Stocks These young geniuses pocket enormous sums of money by solving seemingly intractable problems. Rather than simply poaching market share from older companies, they use technology to create win-win situations, thus opening up new spaces of commerce.

They are the “creative” part of “creative destruction,” yet the sight of them can stir feelings of panic in the average investor.

“Why them?” says a little voice in the back of our heads. “Why not me?”

While envy is the easiest road to walk in such cases, this article offers (or at least I hope it does) a different path. The first step in walking this path is to accept that young Pimple-Faced Geniuses (PFGs) are a good thing. Not just for society at large, but for YOU as well.



Tech Stocks

It may seem a little strange at first, because we are raised to think in zero-sum terms. From our earliest days, we are told that success is finite—that if your slice of winning gets smaller, someone else’s must have gotten bigger. It’s a very seductive way of looking at the world, and, to be quite honest, it’s often true.

Example #1: Netflix, Inc.

Netflix, Inc. (NASDAQ:NFLX), for example, managed to add new value to the television industry. Over 104 million users flocked to its streaming service in the last decade, hungry for its all-you-can-watch buffet of movies and TV shows.

Collectively, these subscribers watch one billion hours of content every week. One billion hours a week. Videos load without a second of advertising or buffering, giving customers an uncomplicated viewing experience that they didn’t realize they were missing.

Meanwhile, Netflix continues to add subscribers, revenue, and gains to its share price. That counts as a win for Netflix. And the ability for two wins in a single transaction is what makes technology special.

Below is a chart showing the performance of NFLX stock and CBS stock over the last 10 years. It demonstrates exactly what I’m talking about.

Chart courtesy of Stockcharts.com

Chart courtesy of StockCharts.com

You can see that Netflix stock far outstripped CBS stock. However, investors would still have doubled their money on CBS, which would not have happened in any other industry. History is full of exactly the opposite.

Example #2: Facebook Inc

The story of Zuckerberg creating Facebook Inc (NASDAQ:FB) in a college dorm is now more than legend—it has passed into cultural mythology. However, the trouble with mythology is that it often rewrites history.

We forget, for instance, all the raised eyebrows at Facebook’s $1.1-billion acquisition of Instagram. FB stock was mere months away from its initial public offering when Zuckerberg decided to offer his competition the carrot instead of the stick. Investors did not look upon the deal with a kind eye.

In creating Facebook, though, it’s not clear that Zuckerberg was “taking down” an existing industry. There were forerunners of social media, like MySpace and Friendster, but they fell apart for other reasons. In this example, technology created an entirely new industry where none had previously existed.

Once again, this is a feature that is exclusive to technology companies, and it pays extraordinarily well. Just look at FB stock’s incredible run over the last five years.

FB_all

Chart courtesy of StockCharts.com

All this is by way of saying that technology investments are unique. Economists speak often and loudly about how technology is the key to national productivity, which in turn is the only fuel for economic growth in advanced nations. These two facts are connected.Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Investors Buzz Equity Stocks watch next week

Investors Buzz Equity Stocks to watch next week

Stocks watch next week Key events are scheduled for the companies listed below next week.

Stocks watch next week Key events are scheduled for the companies listed below next week.

Notable earnings reports: Retailers dominate the list this week, led by Target (NYSE:(TGT) on August 16 and Wal-Mart (NYSE:(WMT) on August 17. Also reporting are Coach (NYSE:(COH), Dick’s Sporting Goods (NYSE:(DKS) on August 14; Urban Outfitters (NASDAQ:(URBN), Home Depot (NYSE:(HD) on August 15; Cisco (NASDAQ:((CSCO), L Brands (NYSE:LB) on August 16; Alibaba (NYSE:(BABA), Gap (NYSE:(GPS) on August 17; Foot Locker (NYSE:(FL), Deere (NYSE:(DE) on August 18.

Expected IPO filings: Capitol Investment Corp. (Pending:CIC.U).

Go-shop expiration: Rocket Fuel (NASDAQ:(FUEL) for the Vector deal.

IPO quiet period expirations: Calyxt (Pending:(CLXT) on August 14, Kala Pharmaceuticals (Pending:(KALA) on August 14; PetIQ (Pending:PETQ) on August 15.

Secondary offering lockup expirations: Bluebird Bio (NASDAQ:(BLUE), Carrizo Oil & Gas (NASDAQ:(CRZO), Ziopharm Oncology (NASDAQ:(ZIOP), Loco Oncology (NASDAQ:(LOXO) on August 14; Five Oaks Investment (NYSE:(OAKS), Alcentra Capital (NASDAQ:(ABDC) on August 15; Advance Disposal Services (NYSE:(ADSW) on August 16; Halozyme Therapeutics (NASDAQ:(HALO), Indentiv (NASDAQ:(INVE), Harte Hanks (NYSE:(HHS) on August 17



Stocks watch next week

 

Notable annual meeting: Pangaea Logistics (NASDAQ:(PANL) on August 14, Canadian Goose (NYSE:(GOOS) on August 15, J.M. Smucker (NYSE:(SJM) on August 16.

Special shareholder meetings: Care Capital Properties (NYSE:(CCP), FelCor Lodging (NYSE:(FCH), RLJ Lodging (NYSE:(RLJ) on August 15; Rent-A-Center (NASDAQ:(RCII) on August 17, Albany Molecular Research (NASDAQ:(AMRI) on August 18.

Sales and revenue update: Charles Schwab (NYSE:(SCHW) on August 14.

Credit card charge-off reports: American Express (NYSE:(AXP), Bank of America (NYSE:BAC), Citigroup (NYSE:C), Capital One (NYSE:(CO), Discover Financial (NYSE:DFS), JPMorgan (NYSE:JPM) and Synchrony Financial (NYSE:(SYF).

Analyst/Investor day: Humana (NYSE:(HUM) on August 14; Equifax (NYSE:(EFX) on August 15; Progressive (NYSEARCA:(PGF), Unisys (NYSE:(UIS), IDEXX (NASDAQ:(IDXX) on August 16; Rogers Corporation on August 17.

Media watch: A week after the Disney (NYSE:(DIS)-Netflix bombshell, media heavyweights gather on August 15 at the Nomura Instinet Media & Telecom conference in NYC. Presenters include Akamai (NASDAQ:AKAM), AMC Networks (NYSE:AMC), AT&T (NYSE:T), CBS (NYSE:(CBS), Juniper Networks (NYSE:(JNPR), Lions Gate (LGF.A, LGF.B), Sprint (NYSE:S), Twenty-First Century Fox (NASDAQ:FOXA) and Verizon (NYSE:(VZ). Also of interest is a talk by NBA execs with sports a large streaming wildcard.

FDA watch: Seattle Genetics (NASDAQ:(SGEN) is expected to find out by August 20 if Adcetis has been accepted for review.

Hedge fund watch: Pershing Square will hold a webcast with investors on August 17.

Barron’s mentions: The cover story warns on a 50% drop for Netflix (NASDAQ:(NFLX), while 50% upside is seen for Volkswagen (OTCPK:(VLKAY) with breakup opportunities in the air. Microsoft (NASDAQ:(MSFT) and General Dynamics (NYSE:(GD) land very favorable write-ups. On the flip side, the huge drops from IPO duds Snap (NYSE:(SNAP) and Blue Apron (NYSE:(APRN) catch some attention.

Sources: EDGAR, Bloomberg, Nasdaq.com.

Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



Peru stocks lower after the close on Friday, as losses in the Non-Metal Minerals, Industrials and Mining sectors led shares lower.

PERU STOCKS LOWER AT CLOSE OF TRADE; S&P LIMA GENERAL DOWN 0.02%

PERU STOCKS LOWER AT CLOSE OF TRADE; S&P LIMA GENERAL DOWN 0.02%

Peru stocks lower after the close on Friday, as losses in the Non-Metal Minerals, Industrials and Mining sectors led shares lower.

Peru stocks lower after the close on Friday, as losses in the Non-Metal Minerals, Industrials and Mining sectors led shares lower.

At the close in Lima, the S&P Lima General declined 0.02%.

The best performers of the session on the S&P Lima General were Candente Copper (LM:DNT), which rose 34.62% or 0.0180 points to trade at 0.0700 at the close. Meanwhile, Edegel (LM:EDE) added 2.62% or 0.060 points to end at 2.350 and Volcan Minera (LM:VOL_pb) was up 2.41% or 0.020 points to 0.850 in late trade.

The worst performers of the session were PPX Mining Corp (LM:PPX), which unchanged 6.82% or 0.00 points to trade at 0.04 at the close. Volcan Compania Minera SAA (LM:VOLa) declined 5.56% or 0.100 points to end at 1.700 and Grana Y Monter (LM:GRA) was down 3.81% or 0.080 points to 2.020.




PERU STOCKS LOWER

Falling stocks outnumbered advancing ones on the Lima Stock Exchange by 15 to 10 and 8 ended unchanged.

Shares in PPX Mining Corp (LM:PPX) unchanged to 52-week lows; unchanged 6.82% or 0.00 to 0.04.

Crude oil for September delivery was up 0.37% or 0.18 to $48.77 a barrel. Elsewhere in commodities trading, Brent oil for delivery in October rose 0.17% or 0.09 to hit $51.99 a barrel, while the December Gold Futures contract rose 0.38% or 4.90 to trade at $1295.00 a troy ounce.

USD/PEN was up 0.02% to 3.2488, while EUR/PEN rose 0.61% to 3.8418.

The US Dollar Index Futures was down 0.33% at 92.99.

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)

 Brazil stocks were higher after the close on Friday, as gains in the Consumption, Industrials and Real Estate sectors led shares hig

BRAZIL STOCKS HIGHER AT CLOSE OF TRADE; BOVESPA UP 0.55%

BRAZIL STOCKS HIGHER AT CLOSE OF TRADE; BOVESPA UP 0.55%

 Brazil stocks were higher after the close on Friday, as gains in the Consumption, Industrials and Real Estate sectors led shares hig

 

 Brazil stocks were higher after the close on Friday, as gains in the Consumption, Industrials and Real Estate sectors led shares higher.

At the close in Sao Paulo, the Bovespa rose 0.55%.

The best performers of the session on the Bovespa were JBS SA (SA:JBSS3), which rose 5.66% or 0.45 points to trade at 8.40 at the close. Meanwhile, Kroton Educacional SA (SA:KROT3) added 5.33% or 0.81 points to end at 16.01 and BRF SA (SA:BRFS3) was up 5.26% or 2.05 points to 41.05 in late trade.

The worst performers of the session were EDP – Energias do Brasil SA (SA:ENBR3), which fell 2.75% or 0.40 points to trade at 14.15 at the close. Vale SA (SA:VALE3) declined 2.22% or 0.70 points to end at 30.80 and Petroleo Brasileiro SA PN (SA:PETR4) was down 1.82% or 0.24 points to 12.95.



 Brazil stocks were higher

Rising stocks outnumbered declining ones on the Sao Paulo Stock Exchange by 229 to 174 and 45 ended unchanged.

The CBOE Brazil Etf Volatility, which measures the implied volatility of Bovespa options, was down 3.60% to 27.87.

Gold Futures for December delivery was up 0.39% or 5.08 to $1295.18 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in September rose 0.37% or 0.18 to hit $48.77 a barrel, while the September US coffee C contract rose 1.05% or 1.46 to trade at $140.23 .

USD/BRL was up 0.60% to 3.1944, while EUR/BRL rose 1.11% to 3.7796.

The US Dollar Index Futures was down 0.34% at 92.98.

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)



MEXICO STOCKS LOWER  Mexico stocks were lower after the close on Tuesday, as losses in the Healthcare,

MEXICO STOCKS LOWER AT CLOSE OF TRADE; IPC DOWN 0.12%

MEXICO STOCKS LOWER AT CLOSE OF TRADE; IPC DOWN 0.12%

MEXICO STOCKS LOWER  Mexico stocks were lower after the close on Tuesday, as losses in the Healthcare,

MEXICO STOCKS LOWER  Mexico stocks were lower after the close on Tuesday, as losses in the Healthcare, Consumer Goods&Services and Telecoms Services sectors led shares lower.

At the close in Mexico, the IPC lost 0.12%.

The best performers of the session on the IPC were Grupo Financiero Banorte (MX:GFNORTEO), which rose 3.11% or 3.770 points to trade at 125.120 at the close. Meanwhile, Bolsa Mexicana De Valores SAB De CV (MX:BOLSAA) added 2.09% or 0.640 points to end at 31.220 and Gruma SAB de CV (MX:GRUMAB) was up 1.58% or 3.82 points to 246.14 in late trade.

The worst performers of the session were Genomma Lab Internacional SAB De CV (MX:LABB), which fell 2.68% or 0.610 points to trade at 22.160 at the close. Grupo Elektra , S.A.B. De C.V. (MX:ELEKTRA) declined 1.95% or 15.89 points to end at 799.73 and Nemak SAB de CV (MX:NEMAKA) was down 1.53% or 0.25 points to 16.12.



MEXICO STOCKS LOWER

 

Falling stocks outnumbered advancing ones on the Mexico Stock Exchange by 140 to 91 and 11 ended unchanged.

Shares in Grupo Financiero Banorte (MX:GFNORTEO) rose to all time highs; up 3.11% or 3.770 to 125.120.

Gold Futures for December delivery was up 0.09% or 1.18 to $1265.88 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in September fell 0.57% or 0.28 to hit $49.11 a barrel, while the October Brent oil contract fell 0.69% or 0.36 to trade at $52.01 a barrel.

USD/MXN was down 0.38% to 17.8601, while EUR/MXN fell 0.77% to 20.9822.

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)



Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment,

Two Medical Marijuana Penny Stocks to Watch Out for in the Wake of Complete Weed Legalization in 2017

Weed Legalization in the U.S.

Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment,

Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment, the very profitable medical marijuana business usually gets overlooked. For those investing in marijuana stocks, that’s a big mistake. The top medical marijuana penny stocks have the potential to provide even more lucrative returns.

It’s important to remember that the path to weed legalization in the U.S. is on two different tracks for medicinal and recreational marijuana. While recreational marijuana is gaining steam across the U.S., with Nevada being the latest state to enshrine the legal usage of marijuana into law, it’s still a far ways behind on medicinal marijuana.



 Marijuana Penny Stocks

While the majority of Americans do believe that marijuana should be legalized, both federally and statewide, the process is slow-going in terms of mass legalization. Sure, the most populous state in the country, California, has legal weed, as well as several other states and D.C., but that’s still nowhere near full acceptance. Not to mention that the drug is still illegal federally, meaning that technically, national agents could come in and close down every single recreational marijuana dispensary in the country.

You see, under the Obama administration, while not directly endorsing marijuana use, the former president and his team tacitly condoned states moving towards more legalization as federal agents stayed out of the states’ way once legislation was passed.

With that blow coming towards the Sessions crusade against marijuana and Booker pushing legislation, it was a great past week for the marijuana industry.

So with that good new coming in spades, let’s take a look at the marijuana stock list that shows two medical marijuana stocks I think are two of the top medical marijuana penny stocks.

Top Medical Marijuana Penny Stocks

weed3

Chart courtesy of StockCharts.com

Aphria Inc (TSE:APH)

Aphria has a lot going for it. It’s based out of Canada, which is set to legalize all forms of marijuana use by summer 2018. It has a novel way of growing its product—through greenhouses—that will lend it a competitive advantage. And it already supplies a good portion of medical marijuana to the market.

Canopy Growth Crop (TSE:WEED)

As the biggest player in the marijuana market, with a market cap of nearly $1.5 billion, it’s easy to see why such a huge and respected player in the market would be a solid penny stock.

In fact, it’s quite surprising that WEED stock is among the top medical marijuana penny stocks considering its size, but with the value of its shares well below $10.00, WEED stock is still in the penny stock phase of growth.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

 


 



Buz Investors Best Biotech Stock 2017 The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors.

4 Biotech Stocks to Watch This Quarter

36px) Fz(25px)--sm Fz(32px) Mb(17px)--sm Mb(20px) Mb(30px)--lg Ff($ff-primary) Lts($lspacing-md) Fw($fweight) Fsm($fsmoothing) Fsmw($fsmoothing) Fsmm($fsmoothing) Wow(bw)" data-reactid="3">4 Biotech Stocks to Watch This Quarter

Buz Investors Best Biotech Stock 2017 The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors.

Biotech Stocks The biotech sector could easily continue to grow. Why? The long-term trends that have made the sector an outperformer in the market over the past five years remain in place. Biotechnology stocks continue to maintain a strong pace amid phase trials, new leadership and big investments from insiders.

Before the 2016 U.S. presidential election, the biotech industry itself was in a downward trend with many expecting Hillary Clinton to become president and put pressure on big pharma. Once President Trump took office, biotechnology stocks took on a much brighter spotlight. This has been clearly evidenced by the dramatic shift in the Nasdaq Biotechnology Index (NBI). The index itself has increased by as much as 33% after hitting new highs earlier in July.

In line with this, the Nasdaq Biotech Index (in blue, above) continues to outpace both the S&P500 (in green) and the Nasdaq (in red). The regulatory environment in the U.S. leans in favor of biotechnology, with the Food and Drug Administration offering fast-track approval for some breakthrough drugs, especially those targeting rare diseases.



Biotech Stocks

Oxis International Inc. (OXIS), for example, develops and commercializes innovative immunotherapeutics and has a robust portfolio. Oxis has a portfolio of next-generation cancer initiatives and its lead drug candidate, OXS-1550. In fact, the first patient has begun treatment in a FDA-approved Phase 2 clinical trial of its cancer therapy.

Dr. Daniel Vallera, director of the section on Molecular Cancer Therapeutics at the University of Minnesota Cancer Center, helped develop OXS-1550. He commented on the drug.

“The initiation of Phase 2 patient treatment is a key opportunity to demonstrate the effectiveness of this promising cancer therapy,” Vallera said. “This brings us one step closer to an important alternative to invasive chemotherapies and costly cell therapies, Kite Pharma, Inc. (KITE), Juno Therapeutics (JUNO), for cancer patients.”

Oxis recently announced it has signed a binding letter of intent agreement to acquire Georgetown Translational Pharmaceuticals Inc. Formal completion of this agreement will allow Oxis to acquire Georgetown Translational’s leading candidate, Pain Brake. This therapy is a pain relief drug expected to be submitted to the FDA as a new drug application in 15 to 18 months.

Dr. Kathleen Clarence-Smith, co-founder of Chase Pharmaceuticals Corp. (acquired by Allergan PLC (AGN)), will become the new CEO of Oxis and the company has also proposed a name change to GT Biopharma Inc. as part of the transaction.

Similar to Oxis, Moleculin Biotech Inc. (MBRX) also recently announced adding members to the company. In late July, Moleculin appointed John M. Climaco as an independent member of the board of directors.

“We are pleased to have John join our Board as he brings a wealth of international business successes managing complex operations in addition to his well-established capabilities in capital markets, product commercialization and business development,” Moleculin CEO Walter Klemp said.

Recently, the company has been focused on providing support to help jumpstart the launch of a physician-sponsored investigational new drug (IND) application to study the company’s WP1066. This drug is designed for the treatment of adult brain tumors (glioblastoma).

“By providing additional guidance and data, we think we can help accelerate the ability of the physician investigator to respond to FDA’s requests in a way that will allow the study to begin, which we believe could position WP1066 for a brain tumor trial this year,” Klemp said in a press release.

Moleculin share prices have jumped since late June to as high as $3.75. On July 31, the stock closed at $2.99, which was up over 100% since July 10.

Another biotech stock in focus is BioLineRX Ltd. (BLRX). The company is in its clinical stages and focusing on oncology and immunology. It is currently working on a combination trial of BL-8040 (the company’s lead oncology platform) and atezolizumab in order to develop a cancer immunotherapy combination. Genentech, a member of the Roche Group, has begun a Phase 1b/2 study for BL-8040 in order to evaluate the combination in metastatic pancreatic ductal adenocarcinoma.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )